All Stories
Follow
Subscribe to AGENNIX AG i.L.

09.12.2011 – 09:55

AGENNIX AG i.L.

EANS-DD: AGENNIX AG
Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG

--------------------------------------------------------------------------------
  Notification concerning transactions by persons discharging managerial
  responsibilities pursuant to section 15a of the WpHG, transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is responsible
  for the content of this announcement.
--------------------------------------------------------------------------------

 
Details of the person subject to the disclosure requirement:
--------------------------------------------------------------------------------

Person, triggering the disclosure:
-----------------------------
Name:               dievini Hopp BioTech holding GmbH & Co. KG
                    (Legal person, company or institution)

Reason for the disclosure requirement:
------------------------------
Reason:             Legal person, company or institution closely associated
Relationship:       To a person performing managerial responsibilities

Person performing managerial responsibilities, triggering the disclosure
requirement:

--------------------------------------------------------------------------------
Position:           Member of an administrative or supervisory body

Details of the transaction:
--------------------------------------------------------------------------------

Transaction:
------------
Description of financial instrument:  Ordinary Bearer Shares (no-par value)
ISIN:                DE000A1A6XX4
Type of transaction: Oversubscription
Date:                06.12.2011
Currency:            Euro
Price:               2.95000
No of items:         3115520
Total amount traded: 9,190,784.00000
Place:               OTC
Explanation:         The subscription of the new shares by dievini Hopp BioTech
                     holding GmbH & Co. KG by corresponding oversubscription
                     order in the ongoing capital increase utilizing authorized
                     capital is attributed to both of the named board members.
                     
 



Further inquiry note:
-----------------
Barbara Mueller
Manager, Investor Relations & Corporate Communications 		
Phone: +49 (0)89 8565 2693		
ir@agennix.com
		
In the U.S.: Laurie Doyle		
Senior Director, Investor Relations & Corporate Communications		
Phone: +1 609 524 5884 	 	
laurie.doyle@agennix.com
	


Issuer subject to the publication requirement:
--------------------------------------------------------------------------------

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


issuer:      AGENNIX AG
             Im Neuenheimer Feld 515
             D-69120 Heidelberg
phone:       +49 89 8565 2693
FAX:         +49 89 8565 2610
mail:     ir@agennix.com
WWW:      http://www.agennix.com
sector:      Pharmaceuticals
ISIN:        DE000A1A6XX4
indexes:     CDAX, Prime All Share, Technology All Share
stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin,
             Hamburg, Düsseldorf, Hannover, München 
language:   English
 

Original content of: AGENNIX AG i.L., transmitted by news aktuell